Future studies directly addressing this limitation through pharmacological and genetic targeting of NRP1 in the pulmonary endothelium of animal models of PAH with comprehensive phenotyping, including echocardiography, hemodynamics, and histopathology, are warranted. Here, NRP1 is linked to pulmonary arterial hypertension.